A next-gen Ozempic falls short in a drug trial — and Novo Nordisk stock plunges 20%
Novo Nordisk (NVO) released mixed clinical-trial results for its potential Ozempic successor on Friday, leaving Wall Street ...
Novo Nordisk, Valo Health expand drug discovery collaboration
Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an expanded agreement to discover and develop novel treatments for obesity, ty ...
Yahoo Finance25d
Ozempic maker Novo Nordisk to boost production through acquisition
The logo of the Danish pharmaceutical company Novo Nordisk on the facade of the new German headquarters. Christian Schultz/dpa Danish pharma company Novo Nordisk, makers of weight-loss drugs ...
Bernstein upgrades Novo Nordisk (0QIU) to a Hold
Novo Nordisk (0QIU – Research Report) received a Hold rating and a DKK600.00 price target from Bernstein analyst Florent Cespedes today. The ...